Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed 7 enrolled University of Virginia National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with stage III or stage IV melanoma that cannot be removed by surgery.

Timeline

Start: 2002-08
Primary completion: 2005-11
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	multi-epitope melanoma peptide vaccine	Vaccine	—	—
Background	incomplete Freund's adjuvant	Other / unclassified	—	—
Background	sargramostim	Protein / enzyme biologic	—	—

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Summary

Timeline

Drugs

Indications